CAPOX-Bevacizumab Regimen

Preferred Label : CAPOX-Bevacizumab Regimen;

NCIt synonyms : Capecitabine-Oxaliplatin-Bevacizumab Regimen; CAPOX-Avastin Regimen; CAPOX Plus Bevacizumab; B-CAPOX; CapeOx/Bevacizumab; CAPOX-B;

NCIt related terms : CapeOx and Bevacizumab; CapeOx and Bevacizumab-equi; CapeOx and Bevacizumab-bvzr; CapeOx and Bevacizumab-maly; CapeOx and Bevacizumab-adcd; CapeOx and Bevacizumab-awwb; CapeOx and Bevacizumab-aybi; CapeOx and Bevacizumab-onbe;

NCIt definition : A regimen consisting of bevacizumab, capecitabine and oxaliplatin that may be used in the treatment of colorectal cancer, small bowel, appendiceal, and ampullary adenocarcinoma and mucinous carcinoma of the ovary.;

NCIt note : Source: NCCN Guidelines 2007;

Codes from synonyms : 14197; 127543; 127247; 127469; 127321; 127617; 127173; 127395;

Details

Origin ID

C63609;

UMLS CUI

C1879914;

Est indiqué pour
- Rectal Carcinoma [NCIt concept]
- cancer of rectum [MeSH concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Capecitabine [NCIt concept]
- Oxaliplatin [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Colorectal Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients